{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:12:37Z","timestamp":1782375157987,"version":"3.54.5"},"reference-count":40,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2017.00451","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T12:48:10Z","timestamp":1499777290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.3389","volume":"8","author":[{"given":"Chakradhara Rao S.","family":"Uppugunduri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Storelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vid","family":"Mlakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Huezo-Diaz Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Rezgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Th\u00e9or\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Doffey-Lazeyras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Chalandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Daali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Krajinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/sj.bmt.1701355","article-title":"Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patients.","volume":"22","author":"Al-Rawithi","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"B2","volume":"128","author":"Ansari","year":"2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/bmt.2012.265","article-title":"Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients.","volume":"48","author":"Ansari","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/FTD.0b013e3182a04fc7","article-title":"Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation.","volume":"36","author":"Ansari","year":"2014","journal-title":"Ther. Drug Monit."},{"key":"B5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1124\/dmd.109.030197","article-title":"Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.","volume":"38","author":"Antherieu","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/bmt.2011.254","article-title":"Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT.","volume":"47","author":"Balasubramanian","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/bmt.2015.238","article-title":"Busulfan fludarabine vs busulfan cyclophosphamide as a preparative regimen before allogeneic hematopoietic cell transplantation: systematic review and meta-analysis.","volume":"51","author":"Ben-Barouch","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1073\/pnas.91.4.1480","article-title":"Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases.","volume":"91","author":"Berhane","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1021\/tx800465m","article-title":"Protein modification by acrolein: formation and stability of cysteine adducts.","volume":"22","author":"Cai","year":"2009","journal-title":"Chem. Res. Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/bmt.2010.137","article-title":"Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT.","volume":"46","author":"Cantoni","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/sj.bmt.1705909","article-title":"A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation.","volume":"41","author":"Cesaro","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"B12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1124\/jpet.109.156513","article-title":"Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity.","volume":"331","author":"Conklin","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2014.420","article-title":"Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo).","volume":"8","author":"Gargiulo","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"B14","first-page":"1717","article-title":"Pathobiological effects of acrolein in cultured human bronchial epithelial cells.","volume":"48","author":"Grafstrom","year":"1988","journal-title":"Cancer Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/tx00027a007","article-title":"Bioactivation mechanism of S-(3-oxopropyl)-N-acetyl-L-cysteine, the mercapturic acid of acrolein.","volume":"5","author":"Hashmi","year":"1992","journal-title":"Chem. Res. Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/tid.12364","article-title":"Risk factors for hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplant recipients.","volume":"17","author":"Hayden","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/9781444303537.ch97","article-title":"\u201cKidney and bladder complications of hematopoietic cell transplantation,\u201d in","author":"Hingorani","year":"2009","journal-title":"Thomas Hematopoietic Cell Transplantation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus BK.","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jinorgbio.2004.03.016","article-title":"Inhibition of alcohol dehydrogenase by bismuth.","volume":"98","author":"Jin","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"B20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0022-3565(25)38491-0","article-title":"Cyclophosphamide-induced lung toxicity: mechanism of endothelial cell injury.","volume":"268","author":"Kachel","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/toxsci\/57.1.6","article-title":"The molecular effects of acrolein.","volume":"57","author":"Kehrer","year":"2000","journal-title":"Toxicol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/sj.bmt.1705139","article-title":"Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm.","volume":"36","author":"Leung","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/bmt.2015.162","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival.","volume":"50","author":"Lunde","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1006\/taap.1993.1170","article-title":"Acrolein-induced injury to cultured pulmonary artery endothelial cells.","volume":"122","author":"Patel","year":"1993","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.5114\/aoms.2016.59919","article-title":"Sulforaphane protects against acrolein-induced oxidative stress and inflammatory responses: modulation of Nrf-2 and COX-2 expression.","volume":"12","author":"Qin","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/tx00046a005","article-title":"Acrolein mercapturates: synthesis, characterization, and assessment of their role in the bladder toxicity of cyclophosphamide.","volume":"8","author":"Ramu","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0090-9556(24)14896-9","article-title":"Inhibition of human aldehyde dehydrogenase 1 by the 4-hydroxycyclophosphamide degradation product acrolein.","volume":"27","author":"Ren","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.bbmt.2013.04.005","article-title":"Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.","volume":"19","author":"Rezvani","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/tid.12455","article-title":"Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients.","volume":"17","author":"Ruggeri","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"B30","first-page":"533","article-title":"Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide.","volume":"13","author":"Russell","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"B31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.abb.2015.08.005","article-title":"The busulfan metabolite EdAG irreversibly glutathionylates glutaredoxins.","volume":"583","author":"Scian","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"B32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.bmt.1701523","article-title":"Risk factors for severe hemorrhagic cystitis following BMT.","volume":"23","author":"Seber","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3324\/haematol.2009.016758","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type.","volume":"95","author":"Silva Lde","year":"2010","journal-title":"Haematologica"},{"key":"B34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jchromb.2004.02.008","article-title":"Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide.","volume":"806","author":"Takamoto","year":"2004","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/sj.tpj.6500330","article-title":"Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19.","volume":"5","author":"Timm","year":"2005","journal-title":"Pharmacogenomics J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/sj.bmt.1704240","article-title":"Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation.","volume":"32","author":"Tsuboi","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome.","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/tpj.2013.38","article-title":"The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation.","volume":"14","author":"Uppugunduri","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00216-012-6330-y","article-title":"A novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography-tandem mass spectrometry.","volume":"404","author":"Versace","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejps.2005.08.008","article-title":"Pharmacogenetics of cyclophosphamide in patients with hematological malignancies.","volume":"27","author":"Xie","year":"2006","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T22:15:49Z","timestamp":1750544149000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2017.00451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":40,"alternative-id":["10.3389\/fphar.2017.00451"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2017.00451","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,11]]},"article-number":"451"}}